Who
Hao-Yuan Chuang
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Belite Bio.
In numbers
- Trades disclosed
- 54
- Buys
- 0
- Sells
- 4
- Bought
- $0
- Sold
- $28.0M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Mar 2026
- Last trade
- 8 Sep 2026
- Last filed
- 9 Sep 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $427K2,200 at $194.28 | filing |
| 8 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $806K4,120 at $195.60 | filing |
| 8 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $879K4,475 at $196.47 | filing |
| 8 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $908K4,605 at $197.23 | filing |
| 8 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $507K2,562 at $198.05 | filing |
| 8 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $427K2,200 at $194.28 | filing |
| 8 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $806K4,120 at $195.60 | filing |
| 8 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $879K4,475 at $196.47 | filing |
| 8 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $908K4,605 at $197.23 | filing |
| 8 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $507K2,562 at $198.05 | filing |
| 4 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $294K1,633 at $180.16 | filing |
| 4 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $1.2M6,200 at $189.22 | filing |
| 4 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $343K1,800 at $190.63 | filing |
| 4 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $1.2M6,200 at $191.09 | filing |
| 4 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $654K3,398 at $192.40 | filing |
| 4 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $889K4,602 at $193.12 | filing |
| 4 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $362K2,000 at $181.05 | filing |
| 4 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $365K2,000 at $182.49 | filing |
| 4 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $689K3,759 at $183.27 | filing |
| 4 Sep 2026filed 9 Sep 2026 | BLTE Belite BioBiotechnology | SEC FORM 4 Sold | $659K3,569 at $184.57 | filing |
News
Belite Bio (NASDAQ:BLTE) CFO Hao-Yuan Chuang Sells 17,962 Sharestickerreport.com · 10 Sep 2026
1 headline in the last 90 days name Hao-Yuan Chuang; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.